Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    August 2019
  1. FRAUSSEN J, Marquez S, Takata K, Beckers L, et al
    Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD(-)CD27(-) Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.
    J Immunol. 2019 Aug 7. pii: jimmunol.1801236. doi: 10.4049/jimmunol.1801236.
    PubMed     Text format     Abstract available


    July 2019
  2. ZHANG X, Kiapour N, Kapoor S, Khan T, et al
    IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2019 Jul 24. pii: jimmunol.1900311. doi: 10.4049/jimmunol.1900311.
    PubMed     Text format     Abstract available


  3. LINDAHL H, Guerreiro-Cacais AO, Bedri SK, Linnerbauer M, et al
    IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis.
    J Immunol. 2019 Jul 10. pii: jimmunol.1900400. doi: 10.4049/jimmunol.1900400.
    PubMed     Text format     Abstract available


    May 2019
  4. PIANCONE F, Saresella M, Marventano I, La Rosa F, et al
    A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis.
    J Immunol. 2019 May 29. pii: jimmunol.1801625. doi: 10.4049/jimmunol.1801625.
    PubMed     Text format     Abstract available


    February 2019
  5. LI R, Rezk A, Ghadiri M, Luessi F, et al
    Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
    J Immunol. 2019 Feb 15. pii: jimmunol.1900114. doi: 10.4049/jimmunol.1900114.
    PubMed     Text format    


    October 2018
  6. KAP YS, Bus-Spoor C, van Driel N, Dubbelaar ML, et al
    Targeted Diet Modification Reduces Multiple Sclerosis-like Disease in Adult Marmoset Monkeys from an Outbred Colony.
    J Immunol. 2018 Oct 19. pii: jimmunol.1800822. doi: 10.4049/jimmunol.1800822.
    PubMed     Text format     Abstract available


    July 2018
  7. WAN X, Pei W, Shahzad KA, Zhang L, et al
    A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4(+) and CD8(+) T Cells.
    J Immunol. 2018 Jul 9. pii: jimmunol.1800108. doi: 10.4049/jimmunol.1800108.
    PubMed     Text format     Abstract available


  8. GALICIA G, Lee DSW, Ramaglia V, Ward LA, et al
    Isotype-Switched Autoantibodies Are Necessary To Facilitate Central Nervous System Autoimmune Disease in Aicda(-/-) and Ung(-/-) Mice.
    J Immunol. 2018 Jul 6. pii: jimmunol.1700729. doi: 10.4049/jimmunol.1700729.
    PubMed     Text format     Abstract available


    March 2018
  9. BELIKAN P, Buhler U, Wolf C, Pramanik GK, et al
    CCR7 on CD4(+) T Cells Plays a Crucial Role in the Induction of Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2018 Mar 16. pii: jimmunol.1701419. doi: 10.4049/jimmunol.1701419.
    PubMed     Text format     Abstract available


    January 2018
  10. WILLING A, Jager J, Reinhardt S, Kursawe N, et al
    Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor Expression.
    J Immunol. 2018 Jan 3. pii: jimmunol.1701213. doi: 10.4049/jimmunol.1701213.
    PubMed     Text format     Abstract available


    October 2017
  11. SERRE L, Girard M, Ramadan A, Menut P, et al
    Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2017 Oct 23. pii: ji1700667. doi: 10.4049/jimmunol.1700667.
    PubMed     Text format     Abstract available


  12. BLANCHFIELD L, Sabatino JJ Jr, Lawrence L, Evavold BD, et al
    NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.
    J Immunol. 2017;199:2680-2691.
    PubMed     Text format     Abstract available


  13. MADIREDDI S, Eun SY, Mehta AK, Birta A, et al
    Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.
    J Immunol. 2017;199:2721-2728.
    PubMed     Text format     Abstract available


    September 2017
  14. HOSOKAWA T, Kimura T, Nada S, Okuno T, et al
    Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive Function.
    J Immunol. 2017;199:2008-2019.
    PubMed     Text format     Abstract available


    June 2017
  15. LIN CC, Edelson BT
    New Insights into the Role of IL-1beta in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    J Immunol. 2017;198:4553-4560.
    PubMed     Text format     Abstract available


  16. SEKI SM, Stevenson M, Rosen AM, Arandjelovic S, et al
    Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.
    J Immunol. 2017;198:4607-4617.
    PubMed     Text format     Abstract available


  17. MORANDI E, Jagessar SA, 't Hart BA, Gran B, et al
    EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis.
    J Immunol. 2017 Jun 7. pii: ji1700178. doi: 10.4049/jimmunol.1700178.
    PubMed     Text format     Abstract available


  18. GIBSON SA, Yang W, Yan Z, Liu Y, et al
    Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.
    J Immunol. 2017;198:4244-4254.
    PubMed     Text format     Abstract available


    May 2017
  19. HOHLFELD R, Steinman L
    T Cell-Transfer Experimental Autoimmune Encephalomyelitis: Pillar of Multiple Sclerosis and Autoimmunity.
    J Immunol. 2017;198:3381-3383.
    PubMed     Text format    


    April 2017
  20. ROTHE T, Ipseiz N, Faas M, Lang S, et al
    The Nuclear Receptor Nr4a1 Acts as a Microglia Rheostat and Serves as a Therapeutic Target in Autoimmune-Driven Central Nervous System Inflammation.
    J Immunol. 2017 Apr 14. pii: 1600638. doi: 10.4049/jimmunol.1600638.
    PubMed     Text format     Abstract available


    March 2017
  21. WU Q, Wang Q, Mao G, Dowling CA, et al
    Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
    J Immunol. 2017 Mar 3. pii: 1601532. doi: 10.4049/jimmunol.1601532.
    PubMed     Text format     Abstract available


    February 2017
  22. LIU R, Ma X, Chen L, Yang Y, et al
    MicroRNA-15b Suppresses Th17 Differentiation and Is Associated with Pathogenesis of Multiple Sclerosis by Targeting O-GlcNAc Transferase.
    J Immunol. 2017 Feb 22. pii: 1601727. doi: 10.4049/jimmunol.1601727.
    PubMed     Text format     Abstract available


  23. SHIRANI A, Stuve O
    Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology.
    J Immunol. 2017;198:1381-1386.
    PubMed     Text format     Abstract available


    January 2017
  24. NEGROTTO L, Correale J
    Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.
    J Immunol. 2017 Jan 27. pii: 1601139. doi: 10.4049/jimmunol.1601139.
    PubMed     Text format     Abstract available


    December 2016
  25. LI R, Rezk A, Ghadiri M, Luessi F, et al
    Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
    J Immunol. 2016 Dec 14. pii: 1601649.
    PubMed     Text format     Abstract available


    November 2016
  26. LOPEZ DE LAPUENTE A, Feliu A, Ugidos N, Mecha M, et al
    Correction: Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
    J Immunol. 2016;197:4177.
    PubMed     Text format    


  27. CLAES N, Fraussen J, Vanheusden M, Hellings N, et al
    Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients.
    J Immunol. 2016 Nov 11. pii: 1502448.
    PubMed     Text format     Abstract available


    October 2016
  28. CHEN D, Ireland SJ, Remington G, Alvarez E, et al
    CD40-Mediated NF-kappaB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
    J Immunol. 2016 Oct 26. pii: 1600782.
    PubMed     Text format     Abstract available


  29. HAHN JN, Kaushik DK, Mishra MK, Wang J, et al
    Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
    J Immunol. 2016 Oct 12. pii: 1600436.
    PubMed     Text format     Abstract available


    September 2016
  30. WANG D, Ghosh D, Islam SM, Moorman CD, et al
    IFN-beta Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2016 Sep 12. pii: 1500411.
    PubMed     Text format     Abstract available


    August 2016
  31. MCARDEL SL, Brown DR, Sobel RA, Sharpe AH, et al
    Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.
    J Immunol. 2016 Aug 31. pii: 1600706.
    PubMed     Text format     Abstract available


  32. AGGELAKOPOULOU M, Kourepini E, Paschalidis N, Simoes DC, et al
    ERbeta-Dependent Direct Suppression of Human and Murine Th17 Cells and Treatment of Established Central Nervous System Autoimmunity by a Neurosteroid.
    J Immunol. 2016 Aug 22. pii: 1601038.
    PubMed     Text format     Abstract available


    May 2016
  33. AGGELAKOPOULOU M, Kourepini E, Paschalidis N, Panoutsakopoulou V, et al
    ERbeta in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
    J Immunol. 2016 May 13. pii: 1600246.
    PubMed     Text format     Abstract available


    April 2016
  34. SHIMOJIMA C, Takeuchi H, Jin S, Parajuli B, et al
    Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2016 Apr 6. pii: 1501457.
    PubMed     Text format     Abstract available


    March 2016
  35. GLATIGNY S, Wagner CA, Bettelli E
    Cutting Edge: Integrin alpha4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2016 Mar 25. pii: 1502614.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: